Statistics

Total Visits

Views
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer111

Select a period of time:

Number of views in the range

Views
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer38

Views

Views
December 20256
January 20262
February 20260
March 20261
April 20267
May 202615
June 20267
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States13
Netherlands7
Argentina3
Germany2
Egypt2
Peru2
Canada2
Brazil1
Ecuador1
France1
 

Top cities views

Views
Groningen6
San Jose4
Lima2
Frankfurt am Main2
Ajax1
Basseterre1
Brockville1
Cairo1
Ciudad Nezahualcoyotl1
Danville1